The ultimate aim of analysis of influenza virus pathogenesis is to understand the role(s) played by each viral gene in each stage of pathogenesis. For influenza virus to produce disease, it must first mediate each of several stages in pathogenesis (19, 35) . These stages, which ultimately lead to disease, include entry, primary replication, spread, and tissue tropism as well as interaction with host defenses and immune systems. Each stage in pathogenesis involves a dynamic interaction of viral and host factors, with each viral function being controlled by specific viral genes. An understanding of these stages in molecular terms will guide efforts to devise prevention and treatment strategies.
The general approach to determining the genetic basis for differences in the virulence of two influenza viruses is to generate genetic reassortants and to perform a genetic analysis to determine whether the observed differences are properties of one or more of the viral genes. All genome segments of influenza viruses have been implicated in pathogenesis by genetic analysis of a variety of influenza virus strains in a variety of host organisms (for reviews, see references 14, 32, and 35) . In most instances, pairs of influenza viruses differ in pathogenicity because of polymorphisms in several genes, thus preventing the assignment of individual gene functions. Consistent with this notion (that influenza virus strains are polymorphic for several genes controlling virulence) is the observation that avirulent parental viruses can complement each other to yield highly virulent reassortant progeny (31) and conversely that avirulent progeny can result from reassortment between two virulent viruses (27) . These findings indicate that a more controlled format of genetic experimentation is required to identify and stidy the discrete functions of individual genes operating in influenza virus pathogenesis. Ideally, the analysis of the molecular-genetic basis of pathogenicity would employ clonally derived virus strains differing in virulence because of differences in one gene. Such a system involving mutations on an otherwise isogenic background is ideal for genetic, biochemical, and functional analyses.
The approach taken in this report to identify genes that control virulence was to determine the genetic basis for the increased virulence of a variant produced by mouse adaptation. It is assumed that adaptation results in the acquisition of functions that are critical determinants of pathogenesis. This is self-evident but is stated since it encompasses the 4524 BROWN Segments 4, 5, 7, and 8 had mutated to result in increased virulence. Viruses that differ in virulence because of mutation in individual genome segments were produced. The fact that adaptation to increased virulence was multigenic and that at least some of these mutations could operate independently of the others suggests that adaptation to increased virulence of influenza virus is an incremental process involving sequential selection of mutations playing specific roles in pathogenesis. Table 2 .
MATERIALS AND METHODS

Viruses
Determination of median plaque-inhibiting titer of immune sera. Rabbit immune sera were used to inhibit plaque formation of specific viruses, thus allowing the selection of specific reassortant types. Immune sera to FM (HlNl), HK (H3N2), and reassortant viruses containing the H3N1 and H1N2 combinations of hemagglutinin and neuraminidase antigens from FM and HK were produced in rabbits inoculated with purified virus. The median plaque-inhibiting titers of antisera were determined by doing a plaque assay in the presence of serial dilutions of the antiserum; the antiserum was present in the agar overlay, and 100 PFU of virus was used in each 35-mm dish. Two titers were determined for each antiserum preparation to determine the inhibition due to the antineuraminidase and antihemagglutinin components. The antihemagglutinin and antineuraminidase titers of antisera specific for HlNl were determined by using virus that contained a homologous hemagglutinin and heterologous neuraminidase (H1N2) and a virus containing a heterologous hemagglutinin and a homologous neuraminidase (H3N1). The same strategy was used to determine the titers of the three other types of antisera. There was no cross-inhibition by antisera against the alternate subtypes of hemagglutinin or neuraminidase. The median plaque-inhibiting dose titers of the antibody preparations were calculated by the Karber method (9) ; values ranged from 103 to 105. Fig.  1 ; the genotyping was unambiguous for all segments, some of which were distinguishable by protein and RNA mobility.
The genotypes of these viruses can be found in Tables 3 and   4 . All of the crosses used in this study are listed in Table 1 , and the genome composition of the viruses used in the crosses is shown in Table 2 .
Since (Table 5) , although HK segment 6 was shown to affect virulence in specific reassortants (Table  3) . Analysis of the test cross indicated that four segments were significantly associated with virulence; segments 4 and 7 were significant at the 0.1 and 1% level, respectively, whereas segments 5 and 8 were significant at the 5% level ( Tables 3  and 4 . Segments 7 and 8 exit the bottom of the gel under the conditions employed.
Confirmation of the role of specific segments of FM-MA in pathogenesis by transfer into the FM genome. To further test the role of specific genes in disease production, genome segments of FM-MA were transferred back into the avirulent FM parent. Segments 6 and 7 were tested in addition to segments 4, 5, and 8. Segment 6 was analyzed further since its effect could have been masked by the HK segment 6 that affected virulence when transferred into an FM genome; also its encoded protein (NA) is known to have mutated on mouse adaptation (Fig. 1) . Segment 7 was also further analyzed since it is possible that FM segment 7 affects virulence in FM x HK reassortants and that FM-MA segment 7 had acquired mutations that increase its role in disease production; its encoded proteins (Ml and M2) are also known to have mutated on mouse adaptation (unpublished data) (Fig. 1) .
It was not possible to distinguish between most of the FM and FM-MA genome segments by using electrophoresis of protein and RNA, thus preventing the direct analysis of FM x FM-MA reassortants. Instead, FM-MA segment 4 was segregated onto an HK genetic background (reassortant E61) and then crossed with an FM x HK reassortant of reciprocal genotype (reassortant G78); this cross was named J (Fig. 2) . Progeny from the J cross were screened by electrophoresis to obtain three reassortants containing only genome segments and proteins that were electrophoretically indistinguishable from FM. Because of the genotypes of the parental strains, these reassortants must contain segment 4 of FM-MA and seven segments from the avirulent parental FM strain. All of these reassortants were more virulent than the FM parental strain, possessing LD50 values of 104-1 to 1046 (Table 6 ). Thus, segment 4 of FM-MA had acquired mutations that were responsible for a 1022-fold increase in virulence. This accounts for half of the increased virulence of FM-MA.
Transfer of FM-MA segments 5, 6, 7, and 8 into the FM genome. Segments 5, 6, 7, and 8 of FM-MA were then individually transferred in combination with FM-MA segment 4 into the parental FM strain, using the same strategy as employed for transfer of segment 4. Since the proteins of FM-MA segments 6 and 7, NA and Ml, are distinguishable from those of FM by SDS-PAGE, these alleles can be exchanged directly in genetic crosses, such as in crosses L and M (Tables 1 and 2 ). The virulence of reassortants containing FM-MA segment 4 in combination with one of each of segments 5, 6, 7, or 8 is shown in Table 6 . Several of these reassortants were less virulent than reassortants containing segment 4 alone, indicating that reversion had occurred (either by back mutation or by suppression) during their preparation. Q7 and Q13 were revertants, thus, no effect could be shown for segment 5. Reassortants containing segments 4 and 6 showed no effect for segment 6 indicated a role for segment 4 and suggested a role for segments 7 and 8. Reversion was a problem encountered in the preparation of reassortants that were the product of extensive backcrosses. Backcrossing was used to produce reassortants containing specific segments and involved crossing reassortants that had been previously produced in the study. FM-MA segments 4, 7, and 8 have an additive effect on virulence. Reassortants from groups J, L, M, P, and Q were derived from the following numbers of crosses: 3, 5, 7, 11, and 11, respectively. Although the FM-MA genes in these reassortants had been manipulated in approximately half of the total number of crosses used to generate specific reassortants that contained them, there was extensive culturing involved, considering that reassortant progeny from each cross (produced in MDCK cells) were subjected to two sequential plaque isolations before being amplified twice in chicken embryo allantoic cavity to make seed and working stocks. Reversion did not appear to pose a problem in analysis of the J group of reassortants, which were generated by using the least number of crosses (three crosses). With this in mind, reassortants were constructed, using a total of three crosses, that contained segments 4, 7, and 8 of FM-MA, with the remainder of the segments from FM. This was done to further test the roles of segments 7 and 8 without the generation of revertants. Three reassortants were obtained with the desired segments (T-SR17, T142, and T154), and all of them were more virulent by an additive effect of segments 4, 7, and 8, as would be predicted from the J9, M13, and P9 reassortants (Table 6) . T-SR17, T142, and T154 viruses possessed LDG8 values that averaged 102.9, being 1036-fold more virulent than FM. This is consistent with the effects seen previously for segments 7 and 8.
A similar genetic cross to the T cross was performed to verify that the increased virulence of P9 and M13 was due in each instance to the same genetic determinants that were operating in the T reassortants and was not due to spontaneous mutations arising on culturing. To do this, the segment Assessment of reversion in MDCK cells versus chicken embryo allantoic cavity. To assess the extent of reversion of FM-MA mutations that control virulence, virulent viruses were subjected to seven serial diluted passages in MDCK cells or in chicken embryo allantoic cavity; FM-MA was passaged in both systems, whereas J9 was passaged in MDCK cells. Table 8 shows the virulence of passages 5 and 7 of FM-MA and J9. FM-MA and J9 were unchanged in virulence on passage in MDCK cells, whereas FM-MA appeared to show some decrease in virulence (1005-fold) after five or seven passages in allantoic membranes. The virulence of these preparations represents the population average. Plaques were isolated from passage 7 of the FM-MA virus populations to measure the virulence of individual viruses present in these populations. All the viruses isolated from MDCK cell passage 7 were as virulent as the original stock virus; however, of 10 FM-MA clones obtained from passage on allantoic membranes, the majority were revertant, with virulence ranging from 101.7 to 104.6 ( Table 9 ).
Viruses that differ in virulence because of mutation in single genome segments. The increase in virulence due to each of the mutated segments responsible for the increase in virulence for FM-MA is: segment 4, 1022-fold; segment 7, 1007-fold; segment 8, 1008-fold; and possibly segment 5, accounting for the remaining 100°-fold increase in virulence.
Viruses have been produced that differ in virulence because of differences in individual genome segments. J9, J41, and J52 differ in virulence from FM because of mutation in segment 4, coding for the hemagglutinin. M13 and T-SR17 differ in virulence from J9 and P9, respectively, because of mutation in segment 7, coding for the Ml and M2 proteins. P9 and T-SR17 differ in virulence from J9 and M13, respectively, because of mutation in segment 8, coding for the NS1 EN-MA X IfK E61 H H H F H H H H and NS2 proteins. These viruses are valuable tools for the determination of the molecular-genetic basis for pathogenicity.
DISCUSSION
This study was done to identify those genes that had mutated to result in the increased virulence of A/FM/1/47-MA. The mouse-adapted variant had increased in virulence because of mutations in four of its genome segments, specifically, segments 4, 5, 7, and 8. The hemagglutinin-encoding segment was the most important determinant followed by the segments coding for the Ml, M2, NS1, NS2, and possibly the NP proteins.
To identify the FM-MA genes that control virulence, A/FM/1/47-MA was crossed with A/HK/l168. This was the traditional approach and, in most other instances employing different viruses and hosts, a combination of genes derived from both parents was shown to be contributing to virulence. This has been termed the "gene constellation effect," in which an optimum combination of genes is required for a genome of a highly virulent strain (25) . Studies primarily involving crosses of avian strains of influenza virus have implicated all genome segments in the control of virulence, depending on the virus-host-disease system studied (see reference 14) . The test cross, FM-MA x HK, resulted in virulent reassortants whose virulence was significantly associated with FM-MA segments 4, 5, 7, and 8. A reference for this cross was the cross of the avirulent, parental FM strain with HK. This was done to control for gene interaction effects such as complementation that could give rise to virulent reassortants that were independent of the mutations that increased the virulence of FM-MA as seen in crosses of other avirulent strains (31) . In the reference cross, segment 7 was the only FM segment that was significantly associated with virulence, although the probability of this was at the margin of significance (P = 0.05). Segment 6 of HK was able to increase virulence when transferred into FM but was not significantly associated with virulence when assayed by the Wilcoxon ranked sum analysis, presumably since its effect on virulence required a specific constellation of genome segments composed primarily of FM segments and thus it was associated with less virulent reassortants as often as with the most virulent reassortants. To confirm the roles of specific mouse-adapted genome segments in controlling virulence, FM-MA genome segments were transferred back into the FM parent. Since segment 6 of HK increases virulence in specific reassortants, it is possible that this gene could mask the effect of a mutant segment 6 of FM-MA and so its role was analyzed further. Segment 7 was also further analyzed even though it appeared to play a role prior to Although reversion was a problem encountered in producing reassortants by backcrossing, it did not appear to occur in every cross, suggesting that selection of revertants was greater for specific reassortants used in backcrossing. Genetic variation has been described for reassortants produced by other workers for which the same combinations of genome segments have different properties (4, 20) . In this study, UV irradiation was not used in the preparation of (7) .
The virulent strains were superseded by attenuated strains. Rather, increased virulence is a consequence of mutations that increase genetic fitness through enhanced replication. By definition, any variant that replaces the original strain has outcompeted it. All mouse lung-adapted strains grow faster and to higher titers than their progenitor strains (2, 6, 23) . Enhanced replication in a host may be direct, involving viral replication per se, or may be indirect by avoiding or overcoming host defenses or barriers that limit or prevent the virus from mediating specific stages in pathogenesis and thus replicating to its fullest possible extent. Viruses may improve replication in the host by overcoming barriers to entrance, spread, primary and secondary replication, and tissue tropism as well as specific and nonspecific aspects of the cellular or humoral immune system that prevent or curtail infection. The mutated genes of FM-MA may be operating at one or more stages of pathogenesis to mediate increased virulence. Factors relating to shedding and transmission of the virus would be important for maintaining viruses in a host population.
Several studies have implicated segments 4, 5, 7, and 8 with virulence or variation in biological properties that may be relevant to pathogenesis. Genetic analysis of the neurovirulent variant of WSN indicated that segment 6 was the most important determinant being required for the cleavage activation of virus in neuroblastoma cell culture and, parallel to my findings, segments 7 and 8 were secondary determinants of virulence that enhanced the growth rate (21, 34) . Although the functions of the NS proteins are unknown, alleles of segment 8 can attenuate human influenza A virus for squirrel monkeys (36) . Mutations in segment 7 could affect the functions of Ml and/or the M2 protein. Both are structural proteins, Ml being the matrix and M2 being an integral component of the envelope (43, 17) . Segment 7 is a critical determinant of viral replication capacity (12) and may be operating to enhance the growth capacity of FM-MA. The M2 mutation is known to confer resistance to the antiviral inhibitor amantidine hydrochloride (10) The HA molecule mediates influenza virus cell binding through a sialyloligosaccharide receptor (24, 39) . The nature of the hemagglutinin is a critical determinant of pathogenicity for avian influenza viruses (reviewed in reference 25). Virulent strains possess hemagglutinin molecules that can be fully activated by cleavage into the mature HAl and HA2 subunits during replication in most avian tissues, whereas the cleavage and thus replication of avirulent strains is restricted to the respiratory and alimentary tracts. The increased virulence of the A/Chicken/Pennsylvania/1370/83 variant is due to a mutation that affects the cleavability of HA (37) . Avirulent avian mutants that are resistant to neutralization by specific monoclonal antibodies and that maintain cleavable hemagglutinin molecules have been obtained, however (22) , indicating that cleavage does not control virulence independent of other factors. Human influenza virus strains do not differ in the cleavability of their hemagglutinins; however, mutants adapted to growth in mammalian cell culture (MDCK cells) have acquired the ability to be cleaved (26) , suggesting that alterations affecting cleavability could be operating in mammals. Specific mutations in influenza virus strains from different hosts have been shown to control properties (distinct from cleavage activation) involved in virus-host interactions such as tropism, host cell selection, receptor binding, and inhibition by nonspecific inhibitors of hemagglutination (38) . Recent genetic analysis of the mouse pneumovirulent variant of A/USSR/ 90/77 indicated that segment 4 and other unidentified segments control its increased virulence (13) . The mutation in HA that controls, in part, the virulence of the A/USSR/90/77 variant has not been fully characterized but is independent of a change in an epitope that bound neutralizing monoclonal antibody (8) .
FM-MA is known to have altered in biological properties compared with FM. FM-MA possesses enhanced growth properties in vivo (mouse lung) and in vitro (MDCK cells) as well as resistance to the alpha and beta inhibitors of hemagglutinin (unpublished data). These and other properties can now be measured in relation to the mutations controlling virulence in FM-MA by using viruses containing the individual genome segments that control virulence. It is conceivable that enhanced replication could be mediated by any or all of the products of segments 4, 5, 7, and 8. The resistance to inhibitors of hemagglutination is probably due to changes in the receptor-binding specificity of the hemagglutinin.
Segments 4, 5, 7, and 8 of FM and FM-MA will be sequenced to identify those mutations that are present on these genome segments. These four genome segments code for six proteins; sequence analysis will identify which of these proteins have been mutated. From SDS-PAGE, FM-MA segment 7 is known to have mutated in both its Ml and M2 proteins, since these proteins have altered electrophoretic mobilities (unpublished data), suggesting that a mutation may reside in the region of the segment that encompasses the overlap between the Ml and M2 genes (16) .
The neuraminidase of FM-MA is mutated as determined by SDS-PAGE of protein but did not appear to play a role in controlling virulence. FM-MA thus possesses a minimum of five mutations involving five genome segments, numbers 4, 5, 6, 7, and 8. I was concerned that FM-MA could possess an excessive amount of unselected mutation that would interfere with the interpretation of sequence analysis. T1 oligonucleotide fingerprinting was done to estimate the number of mutations in FM-MA. The genomes of FM and FM-MA were identical by T1 oligonucleotide mapping (Fig. 3) , indicating that they probably differ by less than 10 nucleotides since this technique analyzes 10 of 15% of the genome (42) . Thus, it is unlikely that unselected mutations will interfere with the interpretation of sequence analysis of the variant relative to the parent. Revertants will be useful for identifying and confirming the roles of specific genetic changes. Once mutations in segments controlling virulence have been identified, it may be possible to generate an FM virus that contains these mutations via an RNA expressed from plasmid DNA, since a vectoring system for introducing foreign genes into influenza virus has been described previously (18) . This would confirm the roles of specific mutations VOL. 64, 1990 on November 6, 2017 by guest http://jvi.asm.org/ Downloaded from 4532 BROWN independent of testing reassortant viruses that may contain unselected mutations.
This study shows that controlled genetic analysis of virulent influenza virus variants can identify genes that control virulence. The effect on virulence of segment 4 is independent of the other mutations that control virulence. Thus, specific genes are playing specific roles in disease production. Viruses that differ because of mutations in single genes, which have been produced in this study, can now be used to define the structural and functional relationships governing the pathogenesis of influenza virus. The fact that specific mutations of FM-MA can operate independently to increase virulence suggests that adaptation to increased virulence is an incremental process involving a series of selected mutational events.
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